Healthcare >> Analyst Interviews >> May 8, 2002
ERIC SCHMIDT is a Managing Director and Senior Research Analyst at SG
Cowen Securities. He joined SG Cowen in 1998 and has been covering
biotechnology stocks for eight years. He was a runner-up in
biotechnology in the 2001 and 2002 Institutional Investor survey. He was
previously a Vice President and Research Analyst for UBS Securities.
Before joining UBS, he co-founded Cambridge Biological Consultants, a
scientific consulting and research firm. He holds a BA in Chemistry from
the University of Pennsylvania and a PhD in Biochemistry from the
Massachusetts Institute of Technology. Profile
biotech? It has been a very busy, high profile area as of late.
What's happening?
Mr. Schmidt: I think we finally figured out what
